• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期低风险子宫内膜癌绝经前女性卵巢保留的风险分层临床病理标准。

Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.

作者信息

Khadraoui Wafa, Tierney Christina, Chung Sophie, Mutlu Levent, Lu Lingeng, Azodi Masoud, Ratner Elena, Menderes Gulden

机构信息

Department of Obstetrics and Gynecology, Yale New Haven Health - Bridgeport Hospital, Bridgeport, CT, USA.

Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.

出版信息

Int J Gynaecol Obstet. 2020 Sep;150(3):385-391. doi: 10.1002/ijgo.13254. Epub 2020 Jun 26.

DOI:10.1002/ijgo.13254
PMID:32506422
Abstract

OBJECTIVE

To establish the rate of occult ovarian micro-metastases in early stage disease and to provide an eligibility framework for providers to consider ovarian preservation in a patient population with presumed early stage disease.

METHODS

A retrospective review from January 2005 to December 2010 identified women with presumed early stage endometrial cancer from a single institutional database. Inclusion criteria included: (1) FIGO grade 1 endometrioid endometrial cancer on endometrial biopsy; or (2) the same pathology as (1) on frozen section specimen with less than 50% myometrial biopsy; and (3) no evidence of metastatic disease on preoperative imaging or visible metastatic disease in the peritoneal cavity.

RESULTS

Of the 52 patients, 86.5% were diagnosed with stage IA and 11.5% were diagnosed with stage II disease. One patient (1.9%) had microscopic adnexal involvement in a fallopian tube, which upstaged her to stage IIA disease. None of the patients had ovarian involvement.

CONCLUSION

Preservation of the ovaries appears to be a safe and viable option for premenopausal women who are diagnosed with presumed early stage endometrioid endometrial cancer. It is believed that ovarian preservation in this select population will provide them with significant health benefits and improve their quality of life.

摘要

目的

确定早期疾病中隐匿性卵巢微转移的发生率,并为医疗服务提供者在假定为早期疾病的患者群体中考虑保留卵巢提供一个资格框架。

方法

对2005年1月至2010年12月期间的数据进行回顾性分析,从一个单一机构数据库中识别出假定为早期子宫内膜癌的女性患者。纳入标准包括:(1)子宫内膜活检显示为FIGO 1级子宫内膜样癌;或(2)冰冻切片标本的病理与(1)相同,且肌层活检少于50%;以及(3)术前影像学检查无转移疾病证据或腹腔内无可见转移疾病。

结果

52例患者中,86.5%被诊断为IA期,11.5%被诊断为II期疾病。1例患者(1.9%)输卵管有微小附件受累,使其分期升至IIA期。无患者有卵巢受累。

结论

对于被诊断为假定为早期子宫内膜样癌的绝经前女性,保留卵巢似乎是一种安全可行的选择。据信,在这一特定人群中保留卵巢将为她们带来显著的健康益处并改善其生活质量。

相似文献

1
Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.早期低风险子宫内膜癌绝经前女性卵巢保留的风险分层临床病理标准。
Int J Gynaecol Obstet. 2020 Sep;150(3):385-391. doi: 10.1002/ijgo.13254. Epub 2020 Jun 26.
2
Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.年轻及绝经前子宫内膜样子宫内膜癌患者卵巢受累的危险因素。
Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:151-154. doi: 10.1016/j.ejogrb.2018.01.030. Epub 2018 Jan 31.
3
[Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].同步原发性子宫内膜癌和卵巢癌的临床病理及生存分析
Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):816-822. doi: 10.3760/cma.j.issn.0529-567x.2018.12.004.
4
Ovarian involvement in endometrioid adenocarcinoma of uterus.卵巢受累于子宫子宫内膜样腺癌。
Gynecol Oncol. 2015 Sep;138(3):532-5. doi: 10.1016/j.ygyno.2015.07.012. Epub 2015 Jul 14.
5
Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.绝经前临床Ⅰ期子宫内膜样腺癌患者卵巢恶性转移的术前预测因素分析。
Sci Rep. 2021 Jan 13;11(1):1219. doi: 10.1038/s41598-020-78953-4.
6
Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.早期子宫内膜癌患者行卵巢保留术的结局:韩国妇科肿瘤学组研究。
Gynecol Oncol. 2013 Nov;131(2):289-93. doi: 10.1016/j.ygyno.2013.08.024. Epub 2013 Aug 29.
7
Ovarian preservation for premenopausal women with early-stage endometrial cancer: a Chinese retrospective study.早期子宫内膜癌绝经前女性的卵巢保留:一项中国回顾性研究。
J Int Med Res. 2019 Jun;47(6):2492-2498. doi: 10.1177/0300060518822432. Epub 2019 Apr 25.
8
Coexisting ovarian malignancy in young women with endometrial cancer.年轻子宫内膜癌女性患者合并卵巢恶性肿瘤。
Obstet Gynecol. 2005 Oct;106(4):693-9. doi: 10.1097/01.AOG.0000172423.64995.6f.
9
Ovarian preservation in young women with endometrial cancer of endometrioid histology.子宫内膜样组织学类型的年轻子宫内膜癌女性患者的卵巢保留
Acta Obstet Gynecol Scand. 2015 Apr;94(4):430-4. doi: 10.1111/aogs.12588. Epub 2015 Mar 1.
10
Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer.I期子宫内膜样子宫内膜癌年轻女性保留卵巢后发生后续卵巢癌的风险
Obstet Gynecol. 2017 Aug;130(2):403-410. doi: 10.1097/AOG.0000000000002142.